Investing Profile

Vincent Brichard

Investor
Senior Vice-president at GlaxoSmithKline Biologicals
Brussels
Photo of Vincent Brichard, Investor
Your Intro Paths to Vincent Brichard
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Vincent Brichard on

cb
Current Investing Position
Investor
Investment Range
$1M - $5.0M
Sweet Spot
$1.5M
Investments On Record
6

Vincent Brichard is on these Sector & Stage Rankings

Vincent Brichard's Investments On Record (5)

CompanyStageDateRound SizeTotal Raised
ATB Therapeutics
Series ANov 2024$57M
$57M
Co-investors: John de Koning (EQT Life Sciences)
Minervax
Series UnknownOct 2023$57M
$140M
Co-investors: Kabeer Aziz (Adjuvant Capital), Christopher Gagliardi (Sanofi Ventures), Veronica Gambillara Fonck (Pureos Bioventures)
ImCheck Therapeutics
Series CJun 2022$100M
Series BDec 2019$53M
$180M
Co-investors: Klaus Breiner (Pureos Bioventures), Rémi Droller (Kurma Partners), Michael Baran (Pfizer Venture Investments), Dr. Regina Hodits (Wellington Partners), Raphael Wisniewski (Andera Partners), Florent Gros (Earlybird Venture Capital)
Egle Therapeutics
Series AOct 2021$47M
$47M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Jacques Mizrahi (Bioqube Ventures)
FoRx Therapeutics
SeedApr 2020$11M
$11M
Co-investors: Denis Patrick (Pfizer Venture Investments), Florian Müllershausen (Novartis Venture Fund), Therese Liechtenstein (M Ventures (Merck)), Vincent Ossipow (Omega Funds)

Vincent Brichard's Experience

Venture Partner EQT Life Sciences2016 - 2022